These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12903868)

  • 1. Pulmonary hypertension in infancy and childhood.
    Gorenflo M; Nelle M; Schnabe PA; Ullmann MV
    Cardiol Young; 2003 Jun; 13(3):219-27. PubMed ID: 12903868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension in the pediatric age.
    Donti A; Formigari R; Ragni L; Manes A; Galiè N; Picchio FM
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in the newborn.
    Greenough A; Khetriwal B
    Paediatr Respir Rev; 2005 Jun; 6(2):111-6. PubMed ID: 15911456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy.
    Keller RL; Moore P; Teitel D; Hawgood S; McQuitty J; Fineman JR
    Pediatr Crit Care Med; 2006 Nov; 7(6):589-94. PubMed ID: 17006391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of pulmonary hypertension in the adolescent.
    Ivy D; Eells P
    Adolesc Med; 2001 Feb; 12(1):79-93. PubMed ID: 11224024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
    Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease.
    Zaidi AN; Dettorre MD; Ceneviva GD; Thomas NJ
    Pediatr Pulmonol; 2005 Sep; 40(3):265-9. PubMed ID: 15830393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pulmonary arterial hypertension associated with congenital heart disease.
    Togănel R; Benedek I; Suteu C; Blesneac C
    Rom J Intern Med; 2007; 45(3):229-34. PubMed ID: 18333354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.
    Kiettisanpipop P; Lertsapcharorn P; Chotivittayatarakorn P; Poovorawan Y
    J Med Assoc Thai; 2007 Oct; 90(10):2053-7. PubMed ID: 18041423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preterm infants with congenital heart disease and bronchopulmonary dysplasia: postoperative course and outcome after cardiac surgery.
    McMahon CJ; Penny DJ; Nelson DP; Ades AM; Al Maskary S; Speer M; Katkin J; McKenzie ED; Fraser CD; Chang AC
    Pediatrics; 2005 Aug; 116(2):423-30. PubMed ID: 16061598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience.
    Choong CK; Sweet SC; Guthrie TJ; Mendeloff EN; Haddad FJ; Schuler P; De La Morena M; Huddleston CB
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):661-9. PubMed ID: 15746752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary hypertension and histological findings before and years after surgical treatment of congenital heart disease (author's transl)].
    Hoffmeister HE; Apitz J; Fischbach H; Stunkat R
    Thoraxchir Vask Chir; 1977 Oct; 25(5):387-90. PubMed ID: 929571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension: physiologic or pathologic disease?
    Soifer SJ
    Crit Care Med; 1993 Sep; 21(9 Suppl):S370-4. PubMed ID: 8365235
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary flow reserve in children with idiopathic pulmonary arterial hypertension: implications for diagnosis and therapy.
    Zimmermann R; Kreuder J; Michel-Behnke I; Voelkel NF; Schranz D
    Eur J Med Res; 2006 May; 11(5):208-13. PubMed ID: 16723295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy].
    Schilling W
    Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.